SourceLess Labs Foundation
1.6.2023 20:02:40 CEST | ACCESS Newswire | Press release
SourceLess Revolutionizes the Blockchain Industry by Unveiling the SourceLess Wallet and wNFT Platform at Web3 Berlin 2023, Europe's Largest Crypto and NFT Conference, Setting the Stage for the First World Wide Blockchain
BERLIN, GERMANY / ACCESSWIRE / June 1, 2023 / SourceLess, a revolutionary blockchain technology company, is set to officially launch its cutting-edge technologies at the upcoming Web3 Berlin 2023 conference. The major event, Europe's largest crypto and NFT gathering, will take place on June 10-11, bringing together an audience of 8,000 attendees and over 300 expert speakers to explore and discuss the latest trends and technologies shaping the future of the Web3 ecosystem.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.Empowering the Future - Sourceless Presents Revolutionary Solutions at Web3 Berlin 2023
With the introduction of the SourceLess Wallet and the wNFT platform, SourceLess aims to reshape the blockchain industry and establish a leading role in this technology space, marking a significant milestone in its mission to create the first World Wide Blockchain.
The ground-breaking innovations SourceLess brings to the table will debut with the SourceLess Wallet - a decentralized crypto wallet that promises unmatched security, privacy, and offline functionality to its users. The wallet features a highly intuitive interface and exclusively encrypts all wallet information on the user's device, eliminating the risks associated with centralized authentication systems.
In parallel, SourceLess introduces the wNFT platform, a gateway to a new era of digital ownership. Going beyond digital art, this platform offers a diverse range of NFTs, each representing lifetime ownership of an STR.domain with real-world benefits. Additionally, the platform hosts valuable utility NFT collections from esteemed partners that bridge the physical and digital realms, providing tangible value to its users.
Through the wNFT platform, users will have the opportunity to acquire STR.domains, which play a central role in the SourceLess ecosystem. These domains offer lifetime ownership, a stable and secure online presence, complete control over digital identity, and the ability to tokenize businesses. They enable the creation of websites or applications with simple commands, boast zero transaction costs, and provide tools for scalability and communication within the ecosystem.
Web3 Berlin 2023 serves as the perfect event for SourceLess to unveil its groundbreaking technologies and marks the first step in establishing its comprehensive ecosystem. As the project continues to develop its offerings, it aims to create a more intelligent and interconnected web - the first World Wide Blockchain.
SourceLess Labs Foundation - Linking the World, Empowering the Future
Contact Information
Iulian Bondari
Head of Marketing
iulian@sourceless.io
+40736595004
SOURCE: SourceLess Labs Foundation
To view this piece of content from stats.newswire.com, please give your consent at the top of this page.View source version on accesswire.com:
https://www.accesswire.com/758620/Empowering-the-Future-SourceLess-Presents-Revolutionary-Solutions-at-Europes-Premier-Crypto-Gathering-Web3-Berlin-2023
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
AGFA HealthCare Named Best in KLAS(R) 2026 Across Three Enterprise Imaging Segments in the United States4.2.2026 15:45:00 CET | Press release
Industry recognition for the third consecutive year reinforces AGFA HealthCare's clinician-first commitment, and leadership in empowering connected, high-performance imaging environments MORTSEL, BE / ACCESS Newswire / February 4, 2026 / AGFA HealthCare today announced that it has been named Best in KLAS® 2026 across three Enterprise Imaging segments in the United States, with two awards earned for the second consecutive year, underscoring the company's continued leadership in delivering clinician-first imaging solutions trusted by healthcare organizations worldwide. The recognition comes as KLAS Research marks its 30th anniversary, celebrating three decades of amplifying the voice of healthcare providers through independent, data-driven insights. AGFA HealthCare's Best in KLAS distinctions reflect strong customer validation of its Enterprise Imaging platform - designed to empower clinicians to stay in their flow, reduce complexity across imaging workflows, and enable confident clinica
Preservica Redefines Digital Preservation with Powerful Built-In AI Tools4.2.2026 15:00:00 CET | Press release
OXFORD, UK and BOSTON, MA / ACCESS Newswire / February 4, 2026 / Preservica, the leader in AI-powered Active Digital Preservation™, today announced the rollout of integrated, human-centered AI tools and flexible AI Credits across its product editions. These new features make AI assistance a seamless part of everyday archival workflows, empowering organizations of all sizes to safely adopt AI and scale its use as their needs grow. "With the sheer volume of digital content in backlogs and being created daily, using AI to assist in archival tasks has now become essential" says Stuart Reed, Chief Product Officer at Preservica "Seamlessly integrating human-centered AI tools across our product editions turns AI for Digital Preservation into reality - enabling organizations of all sizes to accelerate routine work, cut backlogs and enhance discovery." Developed in collaboration with Preservica's user community and refined through the company's highly rated AI Workshop series, these embedded to
Karbon-X Files Quarterly Report on Form 10-Q Highlighting Strong Revenue Growth and Commercial Scale4.2.2026 15:00:00 CET | Press release
CALGARY, AB / ACCESS Newswire / February 4, 2026 / Karbon-X Corp. (OTCQX:KARX) ("Karbon-X" or the "Company"), a vertically integrated climate solutions company, today announced that it has filed its Quarterly Report on Form 10-Q for the six months ended November 30, 2025. The filing highlights continued momentum in Karbon-X's commercial operations, driven by significant revenue growth and the expansion of its global carbon activities across both compliance and voluntary markets. "Over the past several quarters, we transformed Karbon-X from a developing platform into a scaled, revenue-generating global operator," said Chad Clovis, Chief Executive Officer of Karbon-X Corp. "Revenue increased to $56.5 million (USD), compared to $1.3 million (USD) in the prior-year period, reflecting the strength of our commercial strategy and the growing demand for high-integrity carbon solutions. As we continue to invest in scaling our operations, our expanding global footprint, improved profitability, a
Axon Neuroscience's Immunotherapy Selected for a Landmark Combination-Therapy Alzheimer’s Clinical Trial in US, Supported by a USD 151 Million Grant4.2.2026 14:00:00 CET | Press release
Axon Neuroscience's active tau immunotherapy AADvac1 has been selected as the first tau-targeted therapy to enter a groundbreaking U.S. Alzheimer's disease phase 2 clinical trial (supported by a USD 151 million grant) and, simultaneously, a new platform trial for progressive supranuclear palsy (PSP) (supported by a USD 75 million grant) SAN FRANCISCO, CA / ACCESS Newswire / February 4, 2026 / Axon Neuroscience, a global leader in immunotherapy for human neurodegenerative diseases with an internationally recognized scientific team, announces the achievement of two historic milestones with the potential to significantly influence the future treatment of Alzheimer's disease and progressive supranuclear palsy (PSP): 1. AADvac1 Selected as the First Tau Therapy in the Phase 2 Alzheimer's Tau Platform (ATP) Combination-Therapy Trial An independent panel of leading U.S. scientific and clinical experts selected AADvac1 as the first therapy targeting pathological tau protein to be evaluated in
CHAR Technologies Licenses High-Temperature Pyrolysis Technology to GazoTech SAS for Entry Into European Markets4.2.2026 14:00:00 CET | Press release
TORONTO, ON / ACCESS Newswire / February 4, 2026 / CHAR Technologies Ltd. ("CHAR Tech" or "the Company") (TSXV:YES)(FSE:68K) a leader in sustainable biomass energy solutions, today announced that it has entered into a formal technology know-how licensing agreement with GazoTech SAS ("GazoTech"), a France-based energy developer, to support deployment of CHAR Tech's technology in France and selected European markets. The agreement follows recent commissioning progress at CHAR Tech's Thorold Renewable Energy Facility and complements the Company's ongoing development of larger-scale projects in North America. Under the agreement, CHAR Tech is the licensor of its proprietary High-Temperature Pyrolysis ("HTP") technology, granting GazoTech a know-how licence for projects developed in France as well as certain additional European markets, subject to project-by-project application of the licenced technology. GazoTech has multiple projects in development in France, notably: An industrial integr
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom